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Randomized clinical trials have demonstrated improved sur- 
viva1 in patients wilh acute myocardial infarction treated 
wilh intmveaou~ thrombolytic therapy (1.2). Beneficial ef- 
fect> on secondary end pwnts such as vessel patency 131. 
mfaxt SIX (4.51 and ventricular function (6.7) have also 
been shown. Despite many studies in this area. seveml key 
iwws reparding the mechanisms of the survival benefit and 
the relations among recondary end poinls remain unrc- 
solved. In some studier. improved survival has not been 
accompanied by reduced infarct size (81. and other possible 
benefits of thrombolysis such ab limitation of infarct cxpan- 
siont%anda reduced potential f~orlethalarrhythmias(10.1 I) 
have been proposed. In this issue of the Journal. Morgan et 
al. (I?1 provide important additional data regarding the 
relatiun~ among vessel patency. infarct size and ventricular 
function. spxifically documenting a reduction in infarcl size 
among treated pat&s with pdtent infarct-related vessels. 
The T~rsue Plarminogcn Act~valor: Toronlo (TPAT) trial 
wab a randomircd. double-bhnd maI in which I iS palienls 
with acute mvocardiat infwction presenting within 3.75 h 
from the on&i of symptoms were treated with intravenous 
recombinant tissue-type plasminocen activator In-PA) or 
placebo (13). Overall; ;heatudy showed improved venlricu- 
lar function aflrr trealment with rl-PA but failed to detect 
differences in infarct size. The current s1udy IS a rclrospcc- 
live analyrin ui 108 of there patients grouped according to 
infarct-related vessel patency determined by coronary angi- 
ography either early Ii8 hl or late C IO days1 after myocardial 
infarction. Global and regional wall motion were assessed by 
radionuclide vcntriculog~aphy at 3.8 II and arain at 9 days. 
Infarct size was measured by quantiwive single photon 
emission comwted thallium ISPECT) scintigraphy on day S. 
The chief-aims of the study wcrc to determine -the 
relations among early and late vessel patency and inlarct size 
and vcntr~ular function. and to :ISSCS the relation between 
the latter two end points. The data show that infarct size was 
considerably smaller in patients with a patent infarct.relaled 
vessel at IH h (group Al than in those with an occluded 
vcsseI. Strong trends toward both better global and better 
rcgicnal function were also observed. supporting the conclu- 
sion of a relation between patency and infarct size. In 
contrast. vcsscl patency in the group studied only late after 
myocardial infarction (group 6) was not related to either 
infarct size or ventricular function. Presumably this was 
because the late patency group comprised not only patients 
with early patency but also patients with late sponlaneou~ 
rcperfusion. in whom decreased infarct size would not be 
expected. 
A general limitation of this sludy is the relatively small 
number of patients. and the authors correc1ly advise caution 
rcgwding conclusions based on these data, especially when 
no differences are reported. A related weakwry is the larger 
proportion of patients with inferior infarction in the group 
with early patency 172%) compared with that in the group 
with early &patency (45%). On average. irrespective of 
treatment. oalienls with inferior mvacardial infarction have 
a smaller /nfarct and a higher &ion fraction than do 
palients with anterior myocardial infarction (4). Unfortu- 
nately. the greater percent of patients with inferior myocar- 
dial infarction in the group with early patency may be a 
sowe of hiar in the ejection fraction and infarct size results. 
Despite these limitations. the study by Morgan et al. (12) 
oroviden additional evidence that the most obvious correlate 
bf preserved left ventricular function is the early presence of 
a patent infarct-related coronary riflery. Data from the 
Thromhotysis in Myocardial Infarction trial (TIM1 Phase I 
1141) clearly demonstrated that preservation of left ventric- 
ular wall motion was achieved only in patients with initially 
open vessels and in those with suslained reperfusion. In 
palients who had unsuccessful or late reperfusion or who 
had reocclurion. ejeclion fraction either decreased or did not 
chance. Similarlv. in the Western Washineton trial of intra- 
ven& strepto~nase (31. ejection fracti& did not differ 
between contml patients with or without a Patent infarct 
ves~cl nsscssed 10 days after myocardial infarction. 
A possible exception to the conclusion by Morgan et al. 
II21 1ha1 late reperfusion is no1 associated with improved 
ventricular function may be patients with angiogmphically 
visible collateral vessels tc the infarct territory in whom 
even late repctfusion may improve ejection fraction 114). 
Collateral vessels were not assessed in the current study. In 
addition. measurements of ventricular function in the 
present report reflect systolic wall motion at rest. Whether 
late vcwl patency affects diastolic function or contractile 
pcrformanc~ during exercise is unknown. As in most other 
studies. the absolute ejection fracriott difference was small. 
which arguer in law of murc comprehensive schemes to 
w$we the overall effectiveness of thrombolytic therapy 
The infarct size dara in the current study are concordant 
with the regional ejection fraction data and reemphasize the 
imponance of early patency. The lack of u difference in 
infarct size when vewel patency i\ urrecced late is consirtent 
with previous reports showing no decrease m infarct we in 
patients receiving treithuent >3 h afler symptom on~rt (II. 
The Toronto study is noteworthy m that the mean time ho 
treatment with thrombolysis was 3.1 h. thus optimGnp the 
likelihood of demonstrating an e&w on mfarct we. A 
possible weakness in the pre%n report IS the use ofdelqe.1 
(4 h) thallium images to determine infurcl size becsuhe impe 
qualily and counting statistics are reduced at 4 h. Redistri- 
bution images may also undewdmate myocardial salvage a, 
determined by metabolx imaaina with use uf 
I’mFIRuorodeoxyglucose and poriwxemission lomography 
(16). Ouantilalive analvsi% of rest imaaes acauired immedl- 
at& after injection may be a hener approach io derermmmg 
infarct six. The use of newer technetium-litbcled Row 
tracers may allow regional blood flow 10 be evaluated before 
treatment. thus allowing late asressmenr of infarct stze to be 
expressed relative to the urea 81 risk c 1720). 
Morgan et al. (12) also report unique data relaunp infwct 
size to regional function. A close uwrre relation belween 
infarct size and regional wall motion war found among 
patients wilh inhially occluded ve~cl~. but not among 
patients with initially open ~cssel~. even \\hen paticnl\ with 
reocclusion were excluded from the laacr analyst.. Polential 
explanations for the lack of correlation in patient\ with 
inilially open vessels are numerous and include the elfect\ of 
myocardial stunning. Other inverligamrs I5211 haw re. 
ported stronger correlations between infarct size and ejcc- 
lion fraction when both are measured lilte 0 to I: wek\l 
after mywardial infarction. Ano!her explaruuion relate\ 10 
the general limiturions of using ventricuhtr wall modon m 
assess the inbinric coruracdle properties of the ucmricle. 
wilh which infarct size should be more closely related. Wall 
motion not only reflecls inlrinlic conlractilily bur idliu i\ 
a&ted by loading conditions. drugs and the autononuc 
nervous system. none of which would be expected to mllu- 
ence infarc’ size detenninabon. Thereiorc. the luck of cor- 
rclutiou betweer infarct size and with motion in thir muh 
subset of palienls. in whom hemodynamic\ und drug\ were 
not controlled. is not surpriGna. 
Morgan et al. (12) are 10 be commended for data that 
provide insight inlo lhe mechanisms of benefit of Ihrom- 
bolytic 1heraDy. For each IKl palicnl\ treated wilh unrave- 
now thrombolybc therapy. appro\imatrly three IO w byes 
are saved 11.?.??.?3). The TISUC Platmuwaen AcLuor. 
Toronto data are con+wu wilh the hypo!hSx thrill early 
reperfusion of the infxct-related vessel is arwcialed wuh 
reduced infarct sx and prerfrved fuocuon Ihat prevent 
death from confraclile failure. 
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